Can Oscar Health Sustain Its Profit Rebound as Medical Costs Rise?

OSCR, SNDR and TFII made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 23rd, 2026.

Oscar Health (OSCR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company

OSCR, SNDR and TFII made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 23rd, 2026.

Assurant and four other multi-line insurers show improving earnings and operating metrics as higher rates support investment income.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) Director Vanessa Ames Wittman sold 25,000 shares of the stock in a transaction dated Friday, September 18th. The stock was sold at an average price of $32.24, for a total transaction of $806,000.00. Following the sale, the director directly owned 112,121 shares in the company, valued at $3,614,781.04. This represents a 18.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oscar Health, Inc. (OSCR) closed the most recent trading day at $31.29, moving 2.61% from the previous trading session.

Oscar Health (NYSE:OSCR) Shares Gap Down - Time to Sell?